Expect tighter cargo screening; IBM sees barcodes but not RFID in fakes fighting;

> The recent terrorism attempt that involved UPS and Fed Ex will likely soon lead to tighter air cargo screening requirements, but still short of the 100 percent requirement now in force for cargo on passenger airlines. News

> Barcodes and sensors are part of IBM's vision for drug tracking; no mention of RFID. Story/video

> Drugmakers need to be watching the FDA's attempts to change the medical device clearance process, which would let the regulator make major reforms without congressional approval. Article

> The FDA has increased inspections of foreign drug plants and begun to improve the data it keeps on them, but it needs to do more. GAO report

> Pennsylvania has pitched in $4.7 million to persuade Teva Pharmaceuticals to locate a distribution center in Philadelphia. Report

> Startup 3PL OM Healthcare Logistics has signed a five-year deal with CareFusion (San Diego), the spinout from Cardinal Health that is also about a year old. Article

> A cyclotron for generating radioactively tagged isotopes, nine hot cell labs for processing them into vials and syringes, and a 4,000-square-foot cGMP lab for producing clinical trial supplies are part of the new Methodist Hospital Research Institute (TMHRI) in Houston. TMHRI release

> Agilent Technologies has opened a facility in Singapore for manufacturing Liquid Chromatography/Mass Spectrometry (LC/MS) instruments and other life sciences instruments. Agilent release

> Phambili-Dismed, South Africa's largest black-owned pharma manufacturer, is building a $14 million factory for making IV solutions and hygiene products, thanks to funding from the Industrial Development Corporation. Article

> India-based generics maker Aurobindo is expanding its operations in Malta. News

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.